Continued ACR Economics Commission and voluntary member site surveys, research and data-driven advocacy on Capitol Hill, and at CMS and HHS, which has reclaimed approximately $1.75 billion in reimbursement to radiology since 2021.
Advocacy Issues
Advancing your today and relentlessly advocating for an even better tomorrow, our advocacy works hard on the issues that matter to you.
Loading component...
2026 Advocacy Priorities
What matters to you, your practice and your patients matters to us. Here’s what we’re doing about it.
ACR resources and ongoing awareness and advocacy efforts help support radiology practices, which have won up to 90% of NSA independent dispute resolution claims vs. insurers for out-of-network care to date.
Ongoing support for state radiological societies with $95,000 in Scope of Practice grants, tracking 100 SOP bills in 37 states, and helping chapters defeat multiple SOP-creep proposals in 2025.
Monitoring and addressing regulatory issues with decisionmakers, such as 2025 efforts that stopped "B-reader" certification eligibility extension to nonphysicians and preserving quality of federal pneumoconiosis programs, like no-cost black lung screenings for coal miners.
Working with lawmakers and federal agencies to expand ACR Data Science Institute offerings and accelerate and advance safe and effective AI innovation and implementation for patients while initiating sensible payment concepts for these cutting-edge technologies.
ACR continues to back the "Find It Early Act" (breast cancer screening), "Increasing Access to Lung Cancer Screening Act" and other relevant efforts to ensure Americans have access to this lifesaving care.
ACR continues to press legislation introduced in 2025 in both the Senate and House which seeks Congressional intervention to modernize and update the Appropriate Use Criteria section of the Protecting Access to Medicare Act to improve patient care, reduce unnecessary imaging and help optimize radiologist workload.
ACR continues to collaborate with other medical societies and patient groups to ensure the National Institutes of Health, which received a funding increase of $415 million for FY26, is sufficiently funded to support clinical research.



